サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654686

世界のマンモグラフィ装置市場-2025-2033年

Global Mammography Machine Market - 2025-2033

出版日
ページ情報
英文 168 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
世界のマンモグラフィ装置市場-2025-2033年
出版日: 2025年02月13日
発行: DataM Intelligence
ページ情報: 英文 168 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のマンモグラフィ装置市場は、2024年に26億米ドルに達し、2033年には41億米ドルに達すると予測され、予測期間2025年のCAGRは5.1%で成長すると予測されています。

マンモグラフィ装置は、乳房組織の詳細なX線画像（マンモグラムと呼ばれる）を撮影することで、乳がんの早期発見と診断に使用される特殊な医療用画像診断装置です。マンモグラフィ装置の主な目的は、しこり、腫瘍、石灰化などの異常や、乳がんやその他の病状を示す兆候を、自覚症状が出る前に発見することです。

検診用マンモグラフィは、乳がんの早期徴候を発見するために無症状の女性に実施され、診断用マンモグラフィは、しこり、痛み、または以前の検診による異常所見などの徴候や症状がある場合に実施され、経過観察用マンモグラフィは、以前に特定された状態を監視するため、または手術や放射線などの治療後に使用されます。

マンモグラフィ装置の需要は、乳がん患者の増加、技術の進歩、政府の健康への取り組みなど、いくつかの要因によって増加しています。乳がん検診、診断、経過観察のためのマンモグラフィ装置の採用が増加していることも、市場需要を牽引する重要な要因です。例えば、2024年6月、FUJIFIM Indiaヘルスケアは、NM Medical Mumbaiと共同で、放射線科医や放射線技師にFFDM（全視野デジタルマンモグラフィ）技術の高度なトレーニングを提供する初のFUJIFILMスキルラボを立ち上げました。

市場力学：

促進要因と抑制要因

乳がん有病率の上昇

乳がんの有病率の上昇は、マンモグラフィ装置市場の成長を大きく後押ししており、予測期間中も市場を牽引するとみられています。世界保健機関（WHO）によると、2022年には230万人の女性が乳がんと診断されました。乳がんは思春期以降のすべての年齢の女性に罹患しますが、罹患率は人生の後半に上昇します。さらに、Breast Cancer Organizationによると、2024年に浸潤性乳がんと診断された女性は約310,720人で、そのうち16％は米国の50歳未満の女性です。このような罹患率の増加は、診断と治療のために早期検診を必要とする患者をより多く生み出すことになります。

乳がんの早期診断は治療成績と生存率を大幅に改善します。マンモグラフィは、特に40歳以上の女性にとって、乳がん検診のゴールドスタンダードです。この早期発見への関心の高まりが、マンモグラフィの普及を後押ししています。乳がんのリスクは年齢とともに増加します。米国がん協会によると、乳がん患者の約80％が50歳以上の女性で診断されています。世界の人口が高齢化するにつれ、特に平均寿命の長い国々では、定期的な検診のためのマンモグラフィ装置の需要が増え続けています。

乳がん啓発月間やピンクリボン・キャンペーンのような取り組みにより、乳がん早期発見の重要性に対する人々の意識は著しく高まっています。特にインド、中国、ブラジルなどの新興市場では、ライフスタイルの変化や高齢化によって乳がん罹患率が上昇しています。

マンモグラフィ装置の高コスト

マンモグラフィ装置の高額なコストは、特にリソースの少ない環境や新興国において、マンモグラフィ装置市場の成長にとって大きな障壁となっています。マンモグラフィ装置のコストは様々であるが、エントリーレベルの装置の平均価格帯は$55,000から$75,000です。最新のデジタル・マンモグラフィと3Dマンモグラフィ（トモシンセシス）システムの費用はかなり高額になります。デジタルマンモグラフィ装置は、機能（AI統合や高度な画像処理機能など）により、1台あたり15万米ドルから30万米ドルの幅があります。

マンモグラフィ装置の高いメンテナンスコストは、経済的な負担を増加させます。これらの機器は、定期的な校正、サービス契約、ソフトウェアのアップデートが必要であり、これが追加費用につながります。フィルム（古いアナログシステムの場合）や使い捨ての画像コンポーネント、メンテナンス用のスペアパーツなどの消耗品も、継続的なコストにつながります。また、これらのシステムを操作・保守するために訓練を受けた専門家が必要なことも、運用コストを増加させます。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • 製品タイプ別
  • テクノロジー別
  • ディメンション別
  • 用途別
  • 最終用途別
  • 地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 乳がん罹患率の上昇
    • 抑制要因
      • マンモグラフィー装置の高コスト
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名なプレーヤー
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 マンモグラフィ装置市場、製品タイプ別

  • デジタル
  • アナログ

第6章 マンモグラフィ装置市場、テクノロジー別

  • スクリーンフィルムマンモグラフィー
  • フルフィールドデジタルマンモグラフィー

第7章 マンモグラフィ装置市場、ディメンション別

  • 2D
  • 3D

第8章 マンモグラフィ装置市場、用途別

  • スクリーニングマンモグラフィー
  • 診断用マンモグラフィー
  • フォローアップマンモグラフィー

第9章 マンモグラフィ装置市場、最終用途別

  • 病院
  • 診断センター
  • 専門クリニック
  • その他

第10章 マンモグラフィ装置市場、地域別、市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場プレーヤー
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第12章 企業プロファイル

  • GE HealthCare
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Siemens Healthineers AG
  • Hologic, Inc.
  • FUJIFILM Holdings Corporation
  • PLANMED OY
  • Koninklijke Philips N.V.
  • Metaltronica S.p.A.
  • Konica Minolta Healthcare Americas, Inc.
  • Carestream Health
  • CANON MEDICAL SYSTEMS ARGENTINA S.A.

第13章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第14章 付録

目次
Product Code: MI9131

The global mammography machine market reached US$ 2.6 billion in 2024 and is expected to reach US$ 4.1 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

A mammography machine is a specialized medical imaging device used for early detection and diagnosis of breast cancer by capturing detailed X-ray images (called mammograms) of the breast tissue. The primary purpose of the mammography machine is to detect abnormalities such as lumps, tumors, calcifications, or other signs that could indicate breast cancer or other medical conditions, often before any symptoms are noticeable.

Screening mammography is performed on asymptomatic women to detect early signs of breast cancer, diagnostic mammography is performed when there are signs or symptoms such as lumps, pain, or abnormal findings from a previous screening, follow-up mammography is used to monitor previously identified conditions or after treatments like surgery or radiation.

The demand for mammography machines has been increasing due to several factors, including the rise in breast cancer cases, advancements in technology and government health initiatives. The rising adoption of mammography machines for breast cancer screening, diagnosis and follow-ups is also a significant factor driving the market demand. For instance, in June 2024, FUJIFIM India Healthcare in collaboration with NM Medical Mumbai, launched its first Fujifilm Skill Lab for providing advanced training in FFDM (full-field digital mammography) technologies for radiologists and radiographers.

Market Dynamics: Drivers & Restraints

Rising prevalence of breast cancer

The rising prevalence of breast cancer is significantly driving the growth of the mammography machine market and is expected to drive the market over the forecast period. According to the World Health Organization (WHO), in 2022, 2.3 million women were diagnosed with breast cancer. Breast cancer affects women of all ages after puberty, although the incidence rises later in life. Additionally, according to the Breast Cancer Organization, in 2024, approximately 310,720 women diagnosed with invasive breast cancer, 16% of which will be in women younger than 50 years of age in the United States. This growing incidence creates a larger pool of patients who require early screening for diagnosis and treatment.

Early diagnosis of breast cancer greatly improves treatment outcomes and survival rates. Mammography is the gold standard for breast cancer screening, especially for women over the age of 40. This increasing focus on early detection drives greater adoption of mammography machines. The risk of breast cancer increases with age. According to the American Cancer Society, about 80% of breast cancer cases are diagnosed in women over the age of 50. As the global population ages, particularly in countries with longer life expectancies, the demand for mammography machines for regular screenings continues to grow.

Initiatives like Breast Cancer Awareness Month and the Pink Ribbon Campaign have significantly increased public awareness of the importance of early breast cancer detection. This has contributed to rising demand for mammography machines, particularly in emerging markets such as India, China, and Brazil, where breast cancer rates are rising due to lifestyle changes and aging populations.

High cost of mammography machines

The high cost of mammography machines is a significant barrier to the growth of the mammography machine market, especially in low-resource settings and developing countries. The cost of a mammography machine can vary however the average price range for an entry-level machine is $55,000 to $75,000. The cost of modern digital mammography and 3D mammography (Tomosynthesis) systems can be quite high. A digital mammography machine can range from USD 150,000 to USD 300,000 per unit, depending on the features (e.g., AI integration and advanced imaging capabilities).

The high maintenance costs of mammography machines add to the total financial burden. These machines require regular calibration, service contracts and software updates, which can lead to additional expenses. Consumables such as film (for older analog systems) or disposable imaging components and spare parts for maintenance contribute to ongoing costs. The need for trained professionals to operate and maintain these systems also increases operational costs.

Segment Analysis

The global mammography machine market is segmented based on product type, technology, dimension, application, end-user and region.

Product Type:

The digital mammography machine segment is expected to dominate the mammography machine market share

Digital mammography machines provide faster breast screening which further helps to promote early diagnosis of breast cancer. The ability to instantly view and store images digitally speeds up the process, improving workflow efficiency and reducing wait times for patients. With digital systems, images are available within minutes, which allows for quick diagnosis and reduced patient anxiety. Digital mammography reduces the need for physical films and manual development processes, making it more cost-effective in the long term.

For instance, in June 2024, Healthway Medical Network (HMN) launched a new digital mammography machine at its multi-specialty center. This new device offers high-resolution imaging for breast cancer screening, enabling the center's doctors to identify potential abnormalities with better accuracy. Moreover, its adoption is aligned with HMN's initiative of offering comprehensive screenings to promote early diagnosis among patients.

Digital mammography provides better image clarity and higher diagnostic accuracy compared to traditional film-based mammography, particularly for women with dense breast tissue. The ability to digitally manipulate images (contrast, zoom, etc.) also aids in detecting early-stage cancers that might be missed in film mammography.

Geographical Analysis

North America is expected to hold a significant position in the mammography machine market share

Breast cancer is the most common cancer among women in North America especially in the United States and Canada, with a significantly higher incidence compared to many other regions. For instance, according to the American Cancer Society, breast cancer is the second most frequent cancer in women in the United States, and it is the top cause of cancer mortality among Hispanic women. In 2024, 310,720 women were diagnosed with invasive breast cancer, with a projected 42,250 deaths. This high prevalence drives the demand for breast cancer screening and diagnostic tools like mammography machines.

Additionally, according to the Canadian Cancer Society, in 2022, an estimated 28,600 Canadian women were diagnosed with breast cancer. With increasing breast cancer cases, awareness about breast cancer and its early detection is also rising, there is a strong demand for mammography screenings in North America, particularly for women aged 40 and above. Mammography remains the gold standard for early breast cancer detection in the region.

North America has been a leader in the adoption of advanced mammography technologies, such as digital mammography and 3D mammography (tomosynthesis). The adoption of Full-Field Digital Mammography (FFDM) and 3D systems has been particularly strong, thanks to their higher diagnostic accuracy and better detection rates compared to traditional film-based systems.

For instance, in January 2025, GRACE Breast Imaging & Medical Spa of Iowa recently became the first healthcare facility in the United States to install the new Mammomat B.brilliant. The Mammomat B.brilliant is Siemens Healthineers' first completely redesigned mammography machine in over a decade. It includes new 3D image acquisition and reconstruction technology, as well as features for full-field digital mammography or two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.

Asia-Pacific is growing at the fastest pace in the mammography machine market

Awareness campaigns focused on early detection and screening are significantly raising the demand for mammography machines in the region. As breast cancer awareness rises, more women are seeking regular screening, driving the need for modern mammography equipment. In countries like India and China, breast cancer awareness is gradually increasing due to efforts by non-profit organizations, media, and healthcare professionals. These campaigns are encouraging women to get screened regularly, which directly drives demand for mammography machines.

For instance, Breast Cancer Awareness Month, commemorated every October, has a unique importance worldwide, but notably in India. In a nation where breast cancer is growing more common, this awareness month acts as an important effort to educate, empower, and motivate action. This has led to greater utilization of mammography services in metropolitan and rural regions.

Competitive Landscape

The major global players in the mammography machine market include GE HealthCare, Siemens Healthineers AG, Hologic, Inc., FUJIFILM Holdings Corporation, PLANMED OY, Koninklijke Philips N.V., Metaltronica S.p.A., Konica Minolta Healthcare Americas, Inc., Carestream Health, CANON MEDICAL SYSTEMS ARGENTINA S.A. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global mammography machine market report delivers a detailed analysis with 78 key tables, more than 70 visually impactful figures, and 168 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Dimension
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Breast Cancer
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Mammography Machines
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Mammography Machine Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Digital Mammography Machine*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Analog Mammography Machine

6. Mammography Machine Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Screen-Film Mammography*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Full Field Digital Mammography

7. Mammography Machine Market, By Dimension

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 7.1.2. Market Attractiveness Index, By Dimension
  • 7.2. 2D*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. 3D

8. Mammography Machine Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Screening Mammography*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Diagnostic Mammography
  • 8.4. Follow-up Mammography

9. Mammography Machine Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. Mammography Machine Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. GE HealthCare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. Siemens Healthineers AG
  • 12.3. Hologic, Inc.
  • 12.4. FUJIFILM Holdings Corporation
  • 12.5. PLANMED OY
  • 12.6. Koninklijke Philips N.V.
  • 12.7. Metaltronica S.p.A.
  • 12.8. Konica Minolta Healthcare Americas, Inc.
  • 12.9. Carestream Health
  • 12.10. CANON MEDICAL SYSTEMS ARGENTINA S.A.

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us